Evidence for statin therapy in polycystic ovary syndrome

Thozhukat Sathyapalan, Stephen Atkin

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age group that is associated with increased cardiovascular risk. In addition to its lipid-lowering effects, statin therapy has shown been shown to have beneficial pleiotropic effects that may contribute to their reduction in cardiovascular morbidity and mortality. In this review, the effect of statins on PCOS is discussed with reference to the underlying potential mechanism of action.

Original languageEnglish
Pages (from-to)15-22
Number of pages8
JournalTherapeutic Advances in Endocrinology and Metabolism
Volume1
Issue number1
DOIs
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Polycystic Ovary Syndrome
Action Potentials
Age Groups
Morbidity
Lipids
Mortality
Therapeutics

Keywords

  • pleiotrophic action
  • polycystic ovary syndrome
  • statins

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Evidence for statin therapy in polycystic ovary syndrome. / Sathyapalan, Thozhukat; Atkin, Stephen.

In: Therapeutic Advances in Endocrinology and Metabolism, Vol. 1, No. 1, 2010, p. 15-22.

Research output: Contribution to journalReview article

@article{231a9647fbee4d168e2bc4ed82b62121,
title = "Evidence for statin therapy in polycystic ovary syndrome",
abstract = "Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age group that is associated with increased cardiovascular risk. In addition to its lipid-lowering effects, statin therapy has shown been shown to have beneficial pleiotropic effects that may contribute to their reduction in cardiovascular morbidity and mortality. In this review, the effect of statins on PCOS is discussed with reference to the underlying potential mechanism of action.",
keywords = "pleiotrophic action, polycystic ovary syndrome, statins",
author = "Thozhukat Sathyapalan and Stephen Atkin",
year = "2010",
doi = "10.1177/2042018810367984",
language = "English",
volume = "1",
pages = "15--22",
journal = "Therapeutic Advances in Endocrinology and Metabolism",
issn = "2042-0188",
publisher = "Sage Periodicals Press",
number = "1",

}

TY - JOUR

T1 - Evidence for statin therapy in polycystic ovary syndrome

AU - Sathyapalan, Thozhukat

AU - Atkin, Stephen

PY - 2010

Y1 - 2010

N2 - Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age group that is associated with increased cardiovascular risk. In addition to its lipid-lowering effects, statin therapy has shown been shown to have beneficial pleiotropic effects that may contribute to their reduction in cardiovascular morbidity and mortality. In this review, the effect of statins on PCOS is discussed with reference to the underlying potential mechanism of action.

AB - Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age group that is associated with increased cardiovascular risk. In addition to its lipid-lowering effects, statin therapy has shown been shown to have beneficial pleiotropic effects that may contribute to their reduction in cardiovascular morbidity and mortality. In this review, the effect of statins on PCOS is discussed with reference to the underlying potential mechanism of action.

KW - pleiotrophic action

KW - polycystic ovary syndrome

KW - statins

UR - http://www.scopus.com/inward/record.url?scp=79952830809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952830809&partnerID=8YFLogxK

U2 - 10.1177/2042018810367984

DO - 10.1177/2042018810367984

M3 - Review article

C2 - 23148145

AN - SCOPUS:79952830809

VL - 1

SP - 15

EP - 22

JO - Therapeutic Advances in Endocrinology and Metabolism

JF - Therapeutic Advances in Endocrinology and Metabolism

SN - 2042-0188

IS - 1

ER -